Search results
Clene Inc (CLNN) Reports Q3 2023 Financial Results: Significant Survival Benefits and $45. ...
GuruFocus.com via Yahoo Finance· 7 months agoClene Inc (NASDAQ:CLNN) reported a significant survival benefit of 19.3 months and delayed clinical...
Lung cancer deaths cut in half with AstraZeneca pill, large trial finds
NBC Universal via AOL· 1 year agoThe British-Swedish science-led biopharmaceutical company AstraZeneca plc's office in South San...
Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues
Investor's Business Daily· 2 years agoThe Food and Drug Administration approved Mirati Therapeutics' rival to Amgen's lung cancer drug,...
New ways to treat bladder cancer improve survival and shake up the standard of care, new studies...
CNN via AOL· 8 months agoA new combination of cancer medications has been shown in research to extend overall survival in...
Patterson Companies (PDCO) Inks Deal to Expand Product Suite
Zacks via Yahoo Finance· 2 years agoPatterson Companies, Inc. PDCO recently announced that it has, through a subsidiary, inked an...
Amgen says Lumakras cuts risk of lung cancer progression by 34%
Reuters via Yahoo Finance· 2 years agoAmgen Inc's Lumakras pill reduced the risk of disease progression in patients with advanced lung...
Point radiopharma drug results disappoint in prostate cancer study
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: A targeted radiation drug being developed by Indianapolis-based Point BioPharma met its...
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Motley Fool· 2 years agoAmylyx Pharmaceuticals (NASDAQ: AMLX) is up more than 100% over the past three months. The stock...
Big Lots’ cost-cutting efforts helped it ‘maintain liquidity through a challenging period’
Retail Dive via Yahoo Finance· 3 months agoDive Brief: Big Lots’ net sales for Q4 fell 7% to $1.43 billion from $1.54 billion a year ago, the...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 2 weeks agoUS-based pharmaceutical company Bristol Myers Squibb (BMS) has published data from three studies in...